rhTPO + CsA vs CsA in the Treatment of LR-MDS With Thrombocytopenia

NCT07653581 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Lower-risk Myelodysplastic Syndromes

Interventions

DRUG: rhTPO
DRUG: Cyclosporine (CsA)

Sponsor

Peking Union Medical College Hospital